Knowledge Library

Abstract Multicolumn capture chromatography is gaining increased attention lately due to the significant economic and process advantages it offers compared with traditional batch mode chromatography. However, for wide adoption of this technology in clinical and commercial space, it requires scalable models for executing viral validation studies. In this study, viral validation studies were conducted under …Read More >

“Gene therapy, a promising therapeutic approach that corrects disease-causing genetic errors, has spurred an arms race among the world’s largest pharmaceutical companies. Novartis (NYSE: NVS) announced the acquisition of AxeVis for a whopping $8.7 billion in 2018. Roche (NASDAQOTH: RHHBY) agreed to acquire gene therapy developer Spark Therapeutics for $4.8 billion in early 2019. One week …Read More >

NextUp: WuXi AppTec Is Speeding Up Drug Development Worldwide The Chinese pharma company, with its deep South Philadelphia Navy Yard presence, is globally recognized for building an innovative platform that shortens drug discovery and research and development time. By Queen Muse· 7/1/2019, 8:00 a.m. “NextUp” is a weekly NextHealth PHL feature that highlights the local …Read More >

Published in pharma’s almanac – a Nice Insight Magazine Q1 2019 Vol. 5 Number 1 Driving Growth of The Cell and Gene Therapy Sector By Felix Hsu, SVP and Global Head of WuXi Advanced Therapies Abstract: The Senior Vice President and Global Head of WuXi AppTec’s Advanced Therapies business Felix Hsu recently sat down with …Read More >